Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation

BACKGROUND: Andexanet alfa (andexanet) is a modified human factor Xa (FXa) approved for anticoagulation reversal in patients with life‐threatening bleeding treated with rivaroxaban or apixaban. Four‐factor prothrombin complex concentrates (4F‐PCCs) are approved for reversal of vitamin K antagonist–i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Res Pract Thromb Haemost
Egile Nagusiak: Lu, Genmin, Lin, Joyce, Bui, Khanh, Curnutte, John T., Conley, Pamela B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Original Articles ‐ Thrombosis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7695565/
https://ncbi.nlm.nih.gov/pubmed/33313467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12418
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak